Estrogen antagonists and inhibitors in hormone therapy of breast cancer
Dryzhak, V.I.
Voprosy Onkologii 35(7): 771-778
1989
ISSN/ISBN: 0507-3758 PMID: 2528239 Document Number: 334760
Document emailed within 1 workday
Related Documents
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23Magnusson, C.; Weiderpass, E. 2001: Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer Lakartidningen 98(5): 418-421
Tachibana, K.; Ohtake, T.; Saji, S. 2016: III. Novel Endocrine Therapy with Signal Transduction Inhibitors for Hormone Dependent Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(13): 2509-2512
Ciatto, S.; Pacini, P.; Confortini, M.; Massimo, V. 1994: Reliability of immunocytochemical assay of estrogen receptors on breast cancer aspirates as a predictor of clinical response to hormone therapy Acta Cytologica 38(4): 666-667
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Grant, E.C.G. 2017: Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy American Journal of Obstetrics and Gynecology 217(2): 232-233
Zahl, P-Henrik.; Maehlen, J. 2005: Estrogen replacement therapy and breast cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 125(8): 1045; Author Reply 1045
Brewster, W.R.; DiSaia, P.J.; Grosen, E.A.; McGonigle, K.F.; Kuykendall, J.L.; Creasman, W.T. 1999: An experience with estrogen replacement therapy in breast cancer survivors International Journal of Fertility and Women's Medicine 44(4): 186-192
Spicer, D.; Pike, M.C.; Henderson, B.E. 1990: The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer Oncology 4(12): 49-54 59; Discussion 59 62
Rubens, R.D.; Hayward, J.L. 1980: Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2922-2924
Tominaga, T. 1983: Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy Gan no Rinsho. Japan Journal of Cancer Clinics 29(6): 628-631
Nomura, Y.; Abe, Y.; Yamagata, J.; Takenaka, K. 1976: Possible retention of the estrogen-binding capacity after endocrine ablation therapy in the rat and human breast cancer Gan 67(1): 101-104
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Ohtake, T.; Yasuda, M.; Watanabe, K.; Ito, T.; Ito, J.; Miyamoto, K.; Yoshida, S.; Abe, N.; Ishigame, T.; Ishii, M.; Kimijima, I.; Takenoshita, S. 2009: Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1459-1463
Altundag, K. 2018: Concurrent administration of aromatase inhibitors with chemotherapy might show better outcome in high risk hormone-receptor positive early-stage breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1559-1560
Wehrlin, N. 1983: Therapeutics: hormone therapy for breast cancer Revue de l'Infirmiere 33(11): 35-38
Joseph, K.S. 1995: Breast cancer and hormone-replacement therapy New England Journal of Medicine 333(20): 1356; Author Reply 1357-1358
2002: New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use Lakartidningen 99(28-29): 3031-3034
Nachtigall, M.J.; Smilen, S.W.; Nachtigall, R.D.; Nachtigall, R.H.; Nachtigall, L.E. 1992: Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy Obstetrics and Gynecology 80(5): 827-830
McClelland, R.A.; Berger, U.; Miller, L.S.; Powles, T.J.; Jensen, E.V.; Coombes, R.C. 1986: Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer Cancer Research 46(8 Suppl): 4241s-4243s